Search - tctmd.com

Displaying 121 - 140 of 468

Sort: Relevancy | Date

Presentation TCT 2017

Surgical Perspectives on MAC and Bioprosthetic Valve and Ring Failures: Implications for Transcatheter Therapies

Presenter: Mayra Guerrero, John G. Webb, Patrick M. McCarthy

October 31, 2017

Presentation TCT 2017

Paravalvular Leak and Hemolysis After TMVR: Incidence, Diagnosis, and Treatment

Presenter: Vinayak Bapat, Maurice Buchbinder, Carlos E. Ruiz

October 31, 2017

Presentation TCT 2017

SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Samir R. Kapadia

October 31, 2017

Presentation TCT 2017

Frequency/Prevention/Treatment of LVOT Obstruction: Alcohol, Septal, Ablation, and LAMPOON

Presenter: Vinayak Bapat, Maurice Buchbinder, Jaffar M Khan

October 31, 2017

Presentation TCT 2017

The Compelling Saga of Stroke after TAVR: Key Messages From NeuroARC

Presenter: Michael J. Reardon, Didier Tchetche, Alexandra J. Lansky

October 31, 2017

Presentation TCT 2017

Iatrogenic ASD After Transseptal Procedures: How to Assess, When to Close

Presenter: Vinayak Bapat, Maurice Buchbinder, Christian Spies

October 31, 2017

Presentation TCT 2017

Case Presentation: TMVR With Transapical Complications

Presenter: Vinayak Bapat, Maurice Buchbinder, Vinod H. Thourani

October 31, 2017

Presentation TCT 2017

The Global Landscape of TAVR Newcomers

Presenter: Jeffrey J. Popma, John G. Webb, Martin B. Leon

October 31, 2017

Presentation TCT 2017

Transapical Access Update: Complications, Impact On LV Function, and Emerging Closure Devices

Presenter: Vinayak Bapat, Maurice Buchbinder, Hendrik Treede

October 31, 2017

Presentation TCT 2017

Endogenous Tissue Restoration: Preclinical Investigation With Restorative Pulmonary and Aortic Valves

Presenter: Jeffrey J. Popma, John G. Webb, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

Keynote Address: The Spectrum Of TMVR Complications - Frequency, Implications, and Prevention and Treatment

Presenter: Vinayak Bapat, Maurice Buchbinder, Neil E. Moat

October 31, 2017

Presentation TCT 2017

Approval Pathways for Transcatheter Mitral and Tricuspid Valve Therapies

Presenter: Steven F. Bolling, John C Laschinger, Bernard Vasseur

October 31, 2017

Presentation TCT 2017

The Self-expanding Single-operator CENTERA TAVR System

Presenter: Jeffrey J. Popma, John G. Webb, Didier Tchetche

October 31, 2017

Presentation TCT 2017

The Venus A and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

Presenter: Jeffrey J. Popma, John G. Webb, Horst Sievert

October 31, 2017

Presentation TCT 2017

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

Presenter: Howard C. Herrmann, Michael J. Mack

October 31, 2017

Presentation TCT 2017

The Anatomically Correct JenaValve TAVR System Pure AR Treatment

Presenter: Jeffrey J. Popma, John G. Webb, Hendrik Treede

October 31, 2017

Presentation TCT 2017

Transcatheter Mitral Valve Replacement Device Trials: Regulatory Approval Trial Design Considerations

Presenter: Steven F. Bolling, John C Laschinger, Martin B. Leon

October 31, 2017

Presentation TCT 2017

Emerging TMVR 5: Mitraltech - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, Francesco Maisano

October 31, 2017

Presentation TCT 2017

PORTICO Insights From EU Operators (With Case Examples)

Presenter: Ganesh Manoharan

October 31, 2017

Presentation TCT 2017

Emerging TMVR 4: Corona Valve With Amend Ring - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, David Meerkin

October 31, 2017

Advertisement

Surgical Perspectives on MAC and Bioprosthetic Valve and Ring Failures: Implications for Transcatheter Therapies

Paravalvular Leak and Hemolysis After TMVR: Incidence, Diagnosis, and Treatment

SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Frequency/Prevention/Treatment of LVOT Obstruction: Alcohol, Septal, Ablation, and LAMPOON

The Compelling Saga of Stroke after TAVR: Key Messages From NeuroARC

Iatrogenic ASD After Transseptal Procedures: How to Assess, When to Close

Case Presentation: TMVR With Transapical Complications

The Global Landscape of TAVR Newcomers

Transapical Access Update: Complications, Impact On LV Function, and Emerging Closure Devices

Endogenous Tissue Restoration: Preclinical Investigation With Restorative Pulmonary and Aortic Valves

Keynote Address: The Spectrum Of TMVR Complications - Frequency, Implications, and Prevention and Treatment

Approval Pathways for Transcatheter Mitral and Tricuspid Valve Therapies

The Self-expanding Single-operator CENTERA TAVR System

The Venus A and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

The Anatomically Correct JenaValve TAVR System Pure AR Treatment

Transcatheter Mitral Valve Replacement Device Trials: Regulatory Approval Trial Design Considerations

Emerging TMVR 5: Mitraltech - Device Description, Critical Appraisal, and Development Plans

PORTICO Insights From EU Operators (With Case Examples)

Emerging TMVR 4: Corona Valve With Amend Ring - Device Description, Critical Appraisal, and Development Plans

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content